Home
 /
Papers
 /
Genetics
 /
Intercellular communication is a heritable dimension of human tissue architecture
Preprint
Open access
V1
Top 1% · Validated by QED

Intercellular communication is a heritable dimension of human tissue architecture

Chen Yang, Xianyang Zhang, Jun Chen
April 2026
 ·
bioRxiv
 ·
DOI 
10.64898/2026.03.29.715138
94
%
Reproducible
QED Impressions
This paper passed independent validation.
QED's automated review checked the evidence supporting each claim, the statistical methods, and whether the results are reproducible from the data provided.

It ranks in the top 1% of preprints assessed in Genetics this quarter.
Run full QED analysis
Read paper
Save

Why this is interesting

By proving that complex-trait heritability concentrates at intercellular communication interfaces, EdgeMap overturns the cell-centric view of genetic architecture and unlocks specific ligand–receptor channels—including druggable targets—entirely invisible to standard gene-level approaches.

QED claims analysis

Summary

Complex trait heritability is systematically organized across intercellular communication interfaces in addition to cell-intrinsic programs, with genetic risk concentrating in tissue- and trait-specific ligand–receptor channels that are statistically independent from cell-autonomous signals, replicate across independent datasets and platforms, and identify therapeutically relevant genes largely absent from standard prioritization methods.

See full analysis
Main Claim 1 –

EdgeMap Independently Decomposes Heritability into Node and Edge Components

Supporting evidence

  • EdgeMap Prioritizes Distinct Genes from Node Scores and Standard Methods
Main Claim 2 –

Communication Heritability Enriches in Biologically Coherent Trait–Tissue Pairings

Supporting evidence

  • Cardiovascular Heritability Maps to Growth Factor, ECM, and Adhesion Signaling
  • EdgeMap Recovers Liver PCSK9–SORT1 Lipoprotein Communication Biology
  • Brain Edge Heritability Shows Trait-Specific Ligand–Receptor Pathway Signatures
  • Edge Heritability Depends on Ligand–Receptor Biology, Not Cell Composition
  • Communication Heritability Replicates Across Sections, GWAS Cohorts, and Platforms
  • Edge Genes Enrich for Drug Targets and Elevated GWAS Signal
  • Edge Heritability Is Polygenic Except Concentrated Liver Lipoprotein Pathways

Abstract

Methods that map genetic risk to cells identify disease-relevant tissues and cell types but cannot test whether genetic effects concentrate at molecular interfaces between cells. Here we introduce EdgeMap, which integrates spatial transcriptomics with GWAS summary statistics to partition trait heritability into cell-intrinsic and intercellular components and to resolve the intercellular signal into specific ligand–receptor channels. Across 17 traits and five human tissues, edge heritability is enriched in biologically coherent trait–tissue pairings (3.8-fold; P = 4.4 × 10−6) and replicates across independent tissue sections, GWAS cohorts, and cell-segmented Visium HD. Per-pair decomposition identifies 67 trait-specific channels (FDR < 0.10) organized into convergent pathway families—neurexin–neuroligin synaptic signaling in bipolar disorder, vascular adhesion in cardiovascular traits, and lipoprotein-clearance pathways in liver. Most edge genes are absent from standard gene-level prioritization, supporting intercellular communication as a complementary dimension of genetic architecture.

Related papers

How the QED Score works

QED Score is a validated AI-based quality metric that evaluates life science papers on two dimensions: originality and validity. Each manuscript is anonymized, broken down into its claims and supporting evidence, and examined by specialized AI agents for statistical rigor, consistency across figures, and fit with the existing literature. Scores are percentile ranks, so they're comparable across fields. In blinded tests, expert professors sided with QED Score over journal rank in 75% of decisive cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?